Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia

Autor: Tito Sedda, G. Porcu, L. Cordero, Panagiotis Paliogiannis, E. Defraia, A.M. Carta, Maria Giuseppa Sarobba, Grazia Palomba, E.M. Saba, T. Scotto, Giovanni Baldino, Antonella Manca, Annalisa Cossu, Francesca Capelli, Giovannella Palmieri, Mario Budroni, Antonio Pazzola, Mc Sini, P. Pirina, Maria Colombino, S. Ortu

Publikováno v: Annals of oncology (Dordr., Online) (2015). doi:10.1093/annonc/mdv343
info:cnr-pdr/source/autori:Colombino M, Paliogiannis P, Defraia E, Porcu G, Pazzola A, Cordero L, Palomba G, Sini MC, Manca A, Carta A, Saba EM, Scotto T, Sarobba MG, Capelli F, Ortu S, Baldino G, Sedda T, Pirina P, Budroni M, Cossu A, Palmieri G/titolo:Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia/doi:10.1093%2Fannonc%2Fmdv343/rivista:Annals of oncology (Dordr., Online)/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume

Background: Assessment of the mutational status in EGFR, KRAS, BRAF has become crucial in recent years for the molecular classification of patients with non small cell lung cancer (NSCLC). In this population-based study, we evaluated the incidence ra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c186f1bb0826aa551367fab2e323254c
http://www.cnr.it/prodotto/i/340719

Aflibercept in combination with FOLFIRI for the 2nd-line treatment of patients with metastatic colorectal cancer (MCRC): safety data from a single institute experience

Autor: A.M. Lanzillo, M.B. Aloi, M. Muntoni, M. Dettori, D. Capra, E. Defraia, L. Mascia

Publikováno v: Annals of Oncology. 28:vi15

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b86111127fd96a2648fb5847e60e70f9
https://doi.org/10.1093/annonc/mdx422.042

Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer (SCLC): GOIRC-AIFA FARM6PMFJM trial

Autor: F. Zanelli, A. Ardizzoni, Nicoletta Zilembo, M. Tiseo, Editta Baldini, F. Riccardi, E. Defraia, G.M. Turolla, Francesco Grossi, F. Ambrosio, Saverio Cinieri, Carmelo Tibaldi, A.R. Trolese, Matteo Brighenti, L. Crinò, Vito D'Alessandro, Luigi Boni, Claudio Dazzi, Andrea Camerini

Publikováno v: Annals of Oncology. 27:iv2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b526dbe48d8587d862fa2c0013f11671
https://doi.org/10.1093/annonc/mdw331.03

Patients with Neuroendocrine Neoplasms: prevalence of Ectopic Cushing's Syndrome (ECS) in our experience

Autor: G.S. Porcu, G. Murenu, E. Mascia, D. Massa, G. Almerighi, B. Demontis, C. Pusceddu, P. Sulas, R. Cherchi, F. Bruder, E. Defraia, M. Dessena, C. Loi, M. Barca, G. Sollai, E. Capasso, C. Canu, N. Giannoni, S. Armeni, R. Pinna, B. Stochino

Publikováno v: Annals of Oncology. 26:vi147

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5976329ba48cfbb1f0f6d4fa3a03a2b8
https://doi.org/10.1093/annonc/mdv348.46

Case report: orofacial characteristics of Hallermann-Streiff Syndrome

Autor: E, Defraia, A, Marinelli, M, Alarashi

Publikováno v: European journal of paediatric dentistry. 4(3)

Hallermann in 1948 and Streiff in 1950 described patients characterised by "bird face", congenital cataract, mandibular hypoplasia, and dental abnormalities. The new syndrome was later defined as Hallermann-Streiff Syndrome (HSS), underlining the dif

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3e71a30d237d015e1c94d830bcb6ea0e
https://pubmed.ncbi.nlm.nih.gov/14529338